Kurobe Pharmaceuticals


Public lists: Pharma Startups (4740)

Kurobe Pharmaceuticals is developing a vancomycin formulation for anitbiotic-resistant eye infections.

Kurobe Pharmaceuticals is developing a vancomycin formulation for anitbiotic-resistant eye infections.

Company (Alive / Active)

Phone: 813-579-2550

Fax:

400 N Ashley Drive
Suite 2150
Tampa, 33602
Florida, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kurobe Pharmaceuticals $5M Jun 4, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kurobe Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Tullis Health InvestorsPrivate EquityGreenwich, Connecticut, United StatesSeries A
Private Medical EquityAngel Investor (Group)United StatesSeries A
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Topical vancomycin formulation and methods of use Sep 24, 2014 Jan 26, 2016 Patent